Literature DB >> 22961153

Does a β2-adrenergic receptor-WNK4-Na-Cl co-transporter signal cascade exist in the in vivo kidney?

Shinichi Uchida, Motoko Chiga, Eisei Sohara, Tatemitsu Rai, Sei Sasaki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22961153     DOI： 10.1038/nm.2809

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  4 in total

1.  Epigenetic modulation of the renal β-adrenergic-WNK4 pathway in salt-sensitive hypertension.

Authors:  ShengYu Mu; Tatsuo Shimosawa; Sayoko Ogura; Hong Wang; Yuzaburo Uetake; Fumiko Kawakami-Mori; Takeshi Marumo; Yutaka Yatomi; David S Geller; Hirotoshi Tanaka; Toshiro Fujita
Journal:  Nat Med       Date:  2011-04-17       Impact factor: 53.440

2.  Immunolocalization of WNK4 in mouse kidney.

Authors:  Mayuko Ohno; Keiko Uchida; Teiko Ohashi; Kosaku Nitta; Akihito Ohta; Motoko Chiga; Sei Sasaki; Shinichi Uchida
Journal:  Histochem Cell Biol       Date:  2011-06-10       Impact factor: 4.304

3.  Targeted disruption of the Wnk4 gene decreases phosphorylation of Na-Cl cotransporter, increases Na excretion and lowers blood pressure.

Authors:  Akihito Ohta; Tatemitsu Rai; Naofumi Yui; Motoko Chiga; Sung-Sen Yang; Shih-Hua Lin; Eisei Sohara; Sei Sasaki; Shinichi Uchida
Journal:  Hum Mol Genet       Date:  2009-07-24       Impact factor: 6.150

4.  Dietary electrolyte-driven responses in the renal WNK kinase pathway in vivo.

Authors:  Michelle O'Reilly; Elaine Marshall; Thomas Macgillivray; Manish Mittal; Wei Xue; Chris J Kenyon; Roger W Brown
Journal:  J Am Soc Nephrol       Date:  2006-08-09       Impact factor: 10.121
  4 in total
  7 in total

1.  Sympathetic regulation of NCC in norepinephrine-evoked salt-sensitive hypertension in Sprague-Dawley rats.

Authors:  Alissa A Frame; Franco Puleo; Kiyoung Kim; Kathryn R Walsh; Elizabeth Faudoa; Robert S Hoover; Richard D Wainford
Journal:  Am J Physiol Renal Physiol       Date:  2019-10-14

2.  Sympathetic stimulation of thiazide-sensitive sodium chloride cotransport in the generation of salt-sensitive hypertension.

Authors:  Andrew S Terker; Chao-Ling Yang; James A McCormick; Nicholas P Meermeier; Shaunessy L Rogers; Solveig Grossmann; Katja Trompf; Eric Delpire; Johannes Loffing; David H Ellison
Journal:  Hypertension       Date:  2014-05-05       Impact factor: 10.190

3.  Norepinephrine-evoked salt-sensitive hypertension requires impaired renal sodium chloride cotransporter activity in Sprague-Dawley rats.

Authors:  Kathryn R Walsh; Jill T Kuwabara; Joon W Shim; Richard D Wainford
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-11-25       Impact factor: 3.619

Review 4.  β2-Adrenergic receptor agonism as a therapeutic strategy for kidney disease.

Authors:  Ali Kamiar; Keyvan Yousefi; Julian C Dunkley; Keith A Webster; Lina A Shehadeh
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2021-02-10       Impact factor: 3.619

Review 5.  Renal sodium handling and sodium sensitivity.

Authors:  Alissa A Frame; Richard D Wainford
Journal:  Kidney Res Clin Pract       Date:  2017-06-30

6.  Mutation affecting the conserved acidic WNK1 motif causes inherited hyperkalemic hyperchloremic acidosis.

Authors:  Hélène Louis-Dit-Picard; Ilektra Kouranti; Chloé Rafael; Irmine Loisel-Ferreira; Maria Chavez-Canales; Waed Abdel-Khalek; Eduardo R Argaiz; Stéphanie Baron; Sarah Vacle; Tiffany Migeon; Richard Coleman; Marcio Do Cruzeiro; Marguerite Hureaux; Nirubiah Thurairajasingam; Stéphane Decramer; Xavier Girerd; Kevin O'Shaugnessy; Paolo Mulatero; Gwenaëlle Roussey; Ivan Tack; Robert Unwin; Rosa Vargas-Poussou; Olivier Staub; Richard Grimm; Paul A Welling; Gerardo Gamba; Eric Clauser; Juliette Hadchouel; Xavier Jeunemaitre
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 19.456

7.  Pinpointing beta adrenergic receptor in ageing pathophysiology: victim or executioner? Evidence from crime scenes.

Authors:  Gaetano Santulli; Guido Iaccarino
Journal:  Immun Ageing       Date:  2013-03-15       Impact factor: 6.400
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.